Karah Parschauer
Overview
Karah Parschauer received an average of $2M in total compensation, including $306K in salary, at Ultragenyx Pharmaceutical from 2016 to 2018.
Source: SEC filings on April 22, 2019 and April 28, 2017.
Related executives
We found nine more executives who work or worked at Ultragenyx Pharmaceutical.
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Officer and Executive Vice President, Translational Sciences
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officer and Executive Vice President
Wladimir Hogenhuis
Ultragenyx Pharmaceutical
Chief Operating Officer
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
Dennis Huang
Ultragenyx Pharmaceutical